Many of these firms do not actually litigate securities class actions. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Rite Aid's stock dropped even further to $0.235, or 8.8%, to close at $2.57, on March 15, 2023. On this news, the price of Rite Aid's stock fell $0.62, or 18.90%, to close at $2.66 per share on March 14, 2023. These practices opened the floodgates for millions of opioid pills and other controlled substances to flow illegally out of Rite Aid's stores."
WHAT IS THIS ABOUT: On March 13, 2023, the United States Depart of Justice ("DOJ") released a statement "alleging that Rite Aid Dispensed Controlled Substances in Violation of the False Claims Act and the Controlled Substances Act." The statement claims that "Rite Aid knowingly filled unlawful prescriptions for controlled substances." According to the Complaint, "Rite Aid's pharmacists repeatedly filled prescriptions for controlled substances with obvious red flags, and Rite Aid intentionally deleted internal notes about suspicious prescribers. toll-free at 86 or email or for information on the class action. WHAT TO DO NEXT: To join the prospective class action, go to or call Phillip Kim, Esq.
The Rosen Law Firm is preparing a class action seeking recovery of investor losses. SO WHAT: If you purchased Rite Aid securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
0 kommentar(er)
